TKI treatment failure is driving up the disease burden of CML
Normin Health just published a study leveraging the existing literature evidence addressing the disease burden of Chinese patients with...
TKI treatment failure is driving up the disease burden of CML
Reducing uncertainty of economic evaluation using real-world data.
Case study for medical devices assessment in real-world setting
Reimbursing infliximab for Crohn's disease is cost-effective in Chinese patients.
Dr. Wendong Chen receives specially-appointed professor from Central South University in China
Cost-Effectiveness of lenalidomide is attractive in Chinese patients with newly diagnosed MM
Flowable gelatin hemostatic matrix gains more clinical benefits in lumbar surgeries
Dr. Wendong Chen gave a talk on real-world studies at THETA round